Apremilast*

600+42.9 mg/5 ml, 100 ml Powder for Oral Suspension (ES)

200+28.5 mg/5 ml, 70 ml and 100 ml Powder for Oral Suspension

400+57 mg/5 ml, 35 ml, 70 ml,100 ml and 140 ml Powder for Oral Suspension

250+125, 500+250, 1000+500 mg (IM/IV) Injectable (vial)

250+125, 500+250, 1000+500 mg (IM) Injectable (vial)

1mg Tablets

10, 20, 40, 80 mg Film Coated Tablet

100 mg SC Injectable (Powder for Injection)

0.05 % Ophthalmic Eye Drops (single-dose)

0.05 % Ophthalmic Eye Drops (LDPE bottle with dropper)

250, 500 mg Film Coated Tablet

100 µg (200 dose) Nasal Spray

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.